1. Home
  2. CLAR vs GANX Comparison

CLAR vs GANX Comparison

Compare CLAR & GANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Clarus Corporation

CLAR

Clarus Corporation

HOLD

Current Price

$2.76

Market Cap

125.2M

ML Signal

HOLD

Logo Gain Therapeutics Inc.

GANX

Gain Therapeutics Inc.

HOLD

Current Price

$2.45

Market Cap

112.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLAR
GANX
Founded
1957
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
125.2M
112.7M
IPO Year
1998
2021

Fundamental Metrics

Financial Performance
Metric
CLAR
GANX
Price
$2.76
$2.45
Analyst Decision
Buy
Strong Buy
Analyst Count
4
6
Target Price
$4.81
$8.00
AVG Volume (30 Days)
273.0K
640.5K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
3.47%
N/A
EPS Growth
11.68
47.95
EPS
N/A
N/A
Revenue
$228,000.00
$55,180.00
Revenue This Year
$7.10
N/A
Revenue Next Year
$7.09
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.83
$1.41
52 Week High
$4.11
$4.34

Technical Indicators

Market Signals
Indicator
CLAR
GANX
Relative Strength Index (RSI) 27.79 49.87
Support Level N/A $1.60
Resistance Level $3.80 $2.93
Average True Range (ATR) 0.13 0.27
MACD -0.03 0.01
Stochastic Oscillator 1.80 36.41

Price Performance

Historical Comparison
CLAR
GANX

About CLAR Clarus Corporation

Clarus Corp is a designer, developer, manufacturer, and distributor of outdoor equipment and lifestyle products focused on the climb, ski, mountain, sport, and skincare markets. The company operates through the Outdoor segment, which includes Black Diamond Equipment and PIEPS, is a world-wide leader in designing, manufacturing, and marketing outdoor engineered equipment and apparel for climbing, mountaineering, trail running, backpacking, skiing, and a wide range of other year-round outdoor recreation activities. The Adventure segment, which includes Rhino-Rack, MAXTRAX and TRED, is a manufacturer of engineered automotive roof racks, trays, mounting systems, luggage boxes, carriers, recovery boards and accessories in Australia and New Zealand and United States.

About GANX Gain Therapeutics Inc.

Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across several therapeutic areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. Geographically, the company operates in Switzerland, Spain, the United States, and Australia.

Share on Social Networks: